Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Bepirovirsen, developed by GlaxoSmithKline (GSK), is a 2-MOE-modified ASO that targets all HBV RNAs, promoting RNase H-mediated RNA degradation, reducing HBV replication, and inhibiting HBsAg production
Anti-inflammatory activity: Researchers report suppression of inflammatory signaling like NF-B, along with reductions in cytokines tied to redness, irritation, and tissue stress
Licensed Peptides prioritizes quality-controlled sourcing to help support product integrity and consistency across laboratory workflows
EASD 2018: the struggles of GSKs GLP-1 receptor agonist , (October 3, 2018)
US$ 28.25
US$ 26.25
US$ 21.89
US$ 20.40
US$ 26.97
US$ 21.25
US$ 21.48
US$ 19.99
US$ 20.04
/s3.gy.digital%2Fboxpharmacy%2Fuploads%2Fasset%2Fdata%2F3411%2FSolgar_L-_Glutathione_50mg.jpg)
US$ 29.66
US$ 21.94
